The $234.7M raise provides a multi-year cash runway for Verastem's clinical pipeline, but the massive dilution (~31M new shares vs. likely pre-offering float) will pressure the stock near-term. Monitor for the final prospectus pricing and any pipeline updates that could offset dilution concerns.
Price Chart
Executive Summary
Verastem priced a public offering of 30,937,500 shares of common stock at $8.00/share and pre-funded warrants to purchase 312,503 shares at $7.9999/warrant, expecting net proceeds of approximately $234.7 million. The offering represents significant dilution for existing shareholders but provides a substantial cash runway for the clinical-stage biotech.
Key Facts
- Offering of 30,937,500 shares of common stock at $8.00 per share
- Pre-funded warrants to purchase up to 312,503 shares at $7.9999 per warrant
- Expected net proceeds of approximately $234.7 million
- Underwriters include Jefferies, Guggenheim, Cantor Fitzgerald, and B. Riley
- Closing expected on or about October 15, 2026
- Pre-funded warrants have $0.0001 exercise price and no expiration
- 60-day lock-up period for company and insiders
Financial Impact
Approximately $234.7 million in net proceeds from the sale of 30,937,500 shares and 312,503 pre-funded warrants
Risk Factors
- Significant dilution to existing shareholders with 30,937,500 new shares issued
- Potential for further dilution if pre-funded warrants are exercised
- Clinical-stage biotech with no approved products — cash burn continues
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-115880 |
| Document: tm2627537d6_ex4-1.htm | 0001104659-26-115880 |
| Document: tm2627537d6_8k.htm | 0001104659-26-115880 |
| Document: tm2627537d6_ex5-1.htm | 0001104659-26-115880 |
| Document: 0001104659-26-115880-index-headers.html | 0001104659-26-115880 |
| Document: 0001104659-26-115880-index.html | 0001104659-26-115880 |
| Document: 0001104659-26-115880.txt | 0001104659-26-115880 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 8-K | $9.23 | awaiting T+60 | — | $10.01 (−8.45%) |
Oct 14, 2026 12d ago | 424B5 | $9.23 | awaiting T+60 | — | $10.01 (−8.45%) |
Oct 14, 2026 12d ago | 424B5 | $9.23 | awaiting T+60 | — | $10.01 (−8.45%) |
Oct 14, 2026 13d ago | 8-K | $7.71 | awaiting T+60 | — | $10.01 (+29.83%) |
Oct 2, 2026 24d ago | Insider Cluster | $8.00 | awaiting T+60 | — | $10.01 (−25.13%) |
Jun 23, 2026 17w ago | 8-K | $3.85 $7.55 | ▲ +96.10% | ▲ +93.27% | $10.01 (+160.00%) |
Jun 17, 2026 18w ago | 8-K | $4.17 $7.32 | ▲ +75.54% | ▲ +72.39% | $10.01 (+140.05%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.10 $8.08 | ▲ +97.07% | ▲ +93.81% | $10.01 (+144.15%) |
Jun 11, 2026 19w ago | Institutional Cluster | $3.94 $8.20 | ▲ +108.12% | ▲ +103.73% | $10.01 (+154.06%) |
May 27, 2026 21w ago | 3 | $4.29 $6.89 | ▲ +60.61% | ▲ +58.87% | $10.01 (+133.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers